DOCSLIB.ORG

Gene Expression Multiplexing Menu

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Gene Expression Multiplexing Menu Gene Expression Multiplexing Menu Mouse Rat Human Table of CONTENTS Mouse Inflammatory Plex ········································2 Rat Stress Plex ···················································3 Growth Regulation Plex ······························4 Multitox Plex ·················································5 Pharma III Plex ·············································6 Reference Plex ·············································7 Human Transporter Plex ··········································8 Pharma III Plex ·············································9 Inflamamatory Plex ····································10 Growth Regulation Plex ······························11 Immunotox Plex ·········································12 Multitox Plex ···············································13 Reference Plex·············································14 Breast Cancer Plex······································15 Multitox Plex ················································16 1 Mouse Inflammatory Plex Mouse Inflammatory Plex Gene Name Accession # 1 Actin, beta (ACTB) X03672 2 Tumor necrosis factor (Tnf) NM_013693 3 Interleukin-6 (IL-6) X54542 4 Membrane cofactor protein (Mcp) NM_010778 5 Matrix metalloproteinase 9 (Mmp9) NM_013599 6 Interferon-gamma inducing factor (IL-18) D49949 7 Interferon-inducible protein 10 receptor (Cxcr3, C-X-C) AB003174 8 Platelet-derived growth factor-inducible KC protein (Cxcl1) J04596 9 Interleukin 4 (Il-4) M25892 10 Interleukin 12b (Il12b) NM_008352 11 Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) NM_001001303 12 Macrophage colony-stimulating factor (Csf) M21952 13 Chemokine (C-C motif) receptor 2 (Ccr2) NM_009915 14 Connective tissue growth factor (Ctgf) NM_010217 15 Transcription factor NF-kappa-B DNA binding subunit M57999 16 Interleukin 10 (IL-10) M37897 17 Interleukin 1 beta (Il1b) NM_008361 18 Fibroblast growth factor 1 (Fgf1) NM_010197 19 Interferon gamma (Ifng) NM_008337 20 T-cell activation gene 3 (TCA3, CCl1, C-C) M17957 21 Kanmycin Resistant 22 Peptidylprolyl isomerase A (Ppia / Cyclophillin A) X52803 23 Signal transducer and activator of transcription 1 (Stat1) NM_009283 24 Interferon regulatory factor 1 (Irf-1) M21065 2 Rat Stress Plex Rat Stress Plex Gene Name Accession # 1 Glutathione reductase (Gsr) NM_053906 2 ATPase inhibitory factor 1 (Atpif1) NM_012915 3 Cyclin-dependent kinase inhibitor 1A, (p21/WAF1) U24174 4 Glutamate cysteine ligase, modifier subunit (Gclm) NM_017305 5 Thioredoxin reductase(TXNR1) U63923 6 Topoisomerase (DNA) 2 alpha (Top2a) NM_022183 7 DnaJ (Hsp40) homolog, subfamily B, member 4 (Dnajb4) NM_001013076 8 Heat shock 10 kDa protein 1 (Hspe1) NM_012966 9 Ornithine transcarbamylase (Otc) NM_013078 10 Heme oxygenase (HMOX-1) J02722 11 Heat shock 70kD protein 1A (Hspa1a) NM_031971 Solute carrier family 10 (sodium/bile acid cotransporter family), 12 NM_017047 member 1 (Slc10a1) 13 Heat shock 90kDa protein 1, beta (Hspcb) NM_001004082 14 Peptidylprolyl isomerase A (Ppia / Cyclophillin A) NM_017101 15 Glutathione S-transferase, mu type 3 (Gstm3) NM_031154 16 Bcl2-associated athanogene 3 (Bag3) NM_001011936 17 Heat shock factor binding protein 1 (Hsbp1) NM_173119 18 Hypoxia up-regulated 1 (Hyou1) NM_138867 19 Actin, beta (ACTB) NM_031144 20 Kanmycin Resistant 21 Biliverdin reductase B (flavin reductase (NADPH)) (Blvrb) XM_214823 22 Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) NM_017008 23 Cytochrome P450, 1a1 (Cyp1a1) NM_012540 3 Rat Multitox Plex Rat Multitox Plex Gene Name Accession # 1 Cyclophilin A NM_017101 2 Cytochrome4A1 (CYP4A22) NM_175837 3 Cytochrome2B1 J00719 4 Cytochrome3A1 L24207 5 Cytochrome2E1 NM_031543 6 Cytochrome P-450 M1 (CYP2C9 orthologue) J02657 7 Cytochrome 2D22 (human CYP2D6 homolog) NM_138515 8 NADPH cytochrome P-450 reductase M12516 9 UDP-glucuronosyltransferase NM_173295 10 Aldehyde dehydrogenase AF001898 11 Cyclin dependent kinase inhibitor 1A (p21) U24174 12 Cytochrome P450 (PB1) 2C19 orthologue M13711 13 Heme Oxygenase (Hmox1) NM_012581 14 NAD(P)H dehydrogenase quinone 1 NM_017000 15 Growth arrest DNA damage 153 (Gadd153) U36994 16 Cyclooxygenase-2 S67722 17 Growth arrest DNA damage 45 L32591 18 Apoptosis related cysteine protease NM_012922 19 CyclinD1 (Ccnd1) NM_171992 20 Proliferating cell nuclear antigen NM_022381 21 Tumor protein p53 NM_030989 22 Cytochrome 1A2 K02422 23 Actin, beta (ACTB) NM_031144 24 Kanmycin Resistant 25 TSC22 L25785 26 Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) NM_017008 27 Cytochrome1A1 NM_012540 5 Rat Growth Regulation Plex Rat Growth Regulation Plex Gene Name Accession # 1 Cyclophilin A NM_017101 2 Cytochrome4A1 (CYP4A22) NM_175837 3 Cytochrome2B1 J00719 4 Cytochrome3A1 L24207 5 Cytochrome2E1 NM_031543 6 Cytochrome P-450 M1 (CYP2C9 orthologue) J02657 7 Cytochrome 2D22 (human CYP2D6 homolog) NM_138515 8 NADPH cytochrome P-450 reductase M12516 9 UDP-glucuronosyltransferase NM_173295 10 Aldehyde dehydrogenase AF001898 11 Cyclin dependent kinase inhibitor 1A (p21) U24174 12 Cytochrome P450 (PB1) 2C19 orthologue M13711 13 Heme Oxygenase (Hmox1) NM_012581 14 NAD(P)H dehydrogenase quinone 1 NM_017000 15 Growth arrest DNA damage 153 (Gadd153) U36994 16 Cyclooxygenase-2 S67722 17 Growth arrest DNA damage 45 L32591 18 Apoptosis related cysteine protease NM_012922 19 CyclinD1 (Ccnd1) NM_171992 20 Proliferating cell nuclear antigen NM_022381 21 Tumor protein p53 NM_030989 22 Cytochrome 1A2 K02422 23 Actin, beta (ACTB) NM_031144 24 Kanmycin Resistant 25 TSC22 L25785 26 Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) NM_017008 27 Cytochrome1A1 NM_012540 5 Rat Pharma III Plex Rat Pharma III Plex Gene Name Accession # 1 Cytochrome P450, family 2, subfamily b, (CYP2B2) polypeptide 2 XM_341808 2 Glutathione-S-transferase, pi 1 (Gstp1) NM_012577 3 CyclinE1 D14015 4 CyclinG1 X70871 5 Trefoil factor 1 (Tff1) NM_057129 6 Insulin-like growth factor binding protein 5 (IGFBP-5) M62781 Cytochrome P450, subfamily IIA (phenobarbital-inducble)/ (Cytochrome P450 7 NM_012542 IIA3) (Cyp2a3a) 8 Cytochrome P450, family 1, subfamily b, polypeptide 1 (Cyp1b1) NM_012940 9 Peroxisome proliferator activated receptor alpha(PPARa) M88592 10 Myelocytomatosis viral oncogene homolog (avian) (c-myc) AY679730 11 Cytochrome P450, subfamily 3A, polypeptide 3 (Cyp3a3) NM_013105 12 Cytochrome P450, family 1, subfamily a, (CYP1A2) polypeptide 2 K02422 13 Baculoviral IAP repeat-containing 5 (Birc5/survivin) AF276775 14 Peptidylprolyl isomerase A (Ppia / Cyclophillin A) NM_017101 15 ATP-binding cassette, sub-family B (MDR/TAP), (Abcb1) member 1 AY082609 16 Myeloblastosis oncogene-like 1 (MYB) XM_232620 17 Cytochrome P450, family 3, subfamily a, (Cyp3a13) polypeptide 13 NM_147206 18 Actin, beta (ACTB) NM_031144 19 Kanmycin Resistant 20 Cytochrome P450, family 2, subfamily d, (Cyp2d13) polypeptide 13 NM_173093 21 Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) NM_017008 6 Rat Reference Plex Rat Reference Plex Gene Name Accession # 1 Beta-glucuronidase M13962 2 Ribosomal protein L37a (RPL37A) X14069 3 Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) NM_017008 4 Ca2-activated neutral protease large subunit BC065306 5 ATP synthase NM_138883 6 Nuclear factor NF45 XM_227385 7 Glycerol kinase NM_024381 8 QRSHs glutaminyl-tRNA synthetase NM_001007624 9 18kDa Alu RNA binding protein XM_215815 10 Histone deacetylase HD1 XM_216349 11 Ezrin AF450298 12 Transferrin Receptor M58040 13 Proteasome subunit Y BC058451 14 Transcription Factor IID XM_226031 15 MLN51 AF525467 16 Lysosomal hyaluronidase AF535141 17 Acidic Ribosomal Protein BC062028 18 Elongation factor EF-1-alpha BC063162 19 Hypoxanthine ribosyl transferase M86443 20 Beta 2 microglobulin NM_012512 21 Peptidylprolyl isomerase A (Ppia / Cyclophillin A) NM_017101 22 Actin, beta (ACTB) NM_031144 23 E2 Ubiquitin conjugating enzyme UbcH5B U13176 24 18s-rRNA M11188 25 Kanmycin Resistant 7 Human Transporter Plex Human Transporter Plex Gene Name Accession # 1 Bile salt export pump (BSEP, ABCB11 ) AF091582 2 Glutathione transferase M1B (GSTM1) J03817 3 ATP-binding cassette, sub-family B (MDR/TAP), member 1 (ABCB1) NM_000927 4 Glutathione S-transferase A1 (GSTA1) NM_145740 5 Glutathione S-transferase pi (GSTP1) NM_000852 6 Peptidylprolyl isomerase A (Ppia / Cyclophillin A) BC000689 7 ATP-binding cassette, sub-family C (CFTR/MRP), member 4 (ABCC4) NM_005845 8 Solute carrier organic anion transporter family, 8 NM_019844 member 1B3 (SLCO1B3, OATP8) ATP-binding cassette, sub-family B (MDR/TAP), 9 NM_000443 member 4 (ABCB4) 10 Human peptide transporter (HPEPT1, SLC15A1 ) U21936 11 Organic cation transporter 1 (hOCT1) U77086 Solute carrier organic anion transporter family, 12 BC042452 member 1A2 (SLCO1A2, OATP-A) 13 Organic anion transporter OATP-C (SLCO1B1) AB026257 ATP-binding cassette, sub-family C (CFTR/MRP), 14 AB019002 member 5 (ABCC5 ) 15 Na/taurocholate cotransporting polypeptide (NTCP, SLC10A1) L21893 16 Actin, beta (ACTB) NM_001101 17 Glutathione S-transferase A2 (GSTA2) NM_000846 18 Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) NM_002046 19 O-6-methylguanine-DNA methyltransferase (MGMT) NM_002412 20 Multidrug resistance-associated protein (MRP, ABCC1) L05628 21 ATP-binding cassette, sub-family C (CFTR/MRP), member 2 (ABCC2) NM_000392 22 Breast cancer resistance protein (BCRP, ABCG2) AF098951 23 Kanmycin Resistant 24 Multidrug resistance-associated protein 3 (MRP3, ABCC3) AF085690 Solute carrier family 2 (facilitated glucose transporter), 25 NM_006516 member 1 (GLUT1, SLC2A1) 26 DNA Topoisomerase I J03250 8 Human Pharma III Plex Human Pharma III Plex Gene Name Accession # 1 Cytochrome P450,
Load more

Recommended publications
  • Serine Proteases with Altered Sensitivity to Activity-Modulating
    (19) & (11) EP 2 045 321 A2 (12) EUROPEAN PATENT APPLICATION (43) Date of publication: (51) Int Cl.: 08.04.2009 Bulletin 2009/15 C12N 9/00 (2006.01) C12N 15/00 (2006.01) C12Q 1/37 (2006.01) (21) Application number: 09150549.5 (22) Date of filing: 26.05.2006 (84) Designated Contracting States: • Haupts, Ulrich AT BE BG CH CY CZ DE DK EE ES FI FR GB GR 51519 Odenthal (DE) HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI • Coco, Wayne SK TR 50737 Köln (DE) •Tebbe, Jan (30) Priority: 27.05.2005 EP 05104543 50733 Köln (DE) • Votsmeier, Christian (62) Document number(s) of the earlier application(s) in 50259 Pulheim (DE) accordance with Art. 76 EPC: • Scheidig, Andreas 06763303.2 / 1 883 696 50823 Köln (DE) (71) Applicant: Direvo Biotech AG (74) Representative: von Kreisler Selting Werner 50829 Köln (DE) Patentanwälte P.O. Box 10 22 41 (72) Inventors: 50462 Köln (DE) • Koltermann, André 82057 Icking (DE) Remarks: • Kettling, Ulrich This application was filed on 14-01-2009 as a 81477 München (DE) divisional application to the application mentioned under INID code 62. (54) Serine proteases with altered sensitivity to activity-modulating substances (57) The present invention provides variants of ser- screening of the library in the presence of one or several ine proteases of the S1 class with altered sensitivity to activity-modulating substances, selection of variants with one or more activity-modulating substances. A method altered sensitivity to one or several activity-modulating for the generation of such proteases is disclosed, com- substances and isolation of those polynucleotide se- prising the provision of a protease library encoding poly- quences that encode for the selected variants.
    [Show full text]
  • Supplementary Table S4. FGA Co-Expressed Gene List in LUAD
    Supplementary Table S4. FGA co-expressed gene list in LUAD tumors Symbol R Locus Description FGG 0.919 4q28 fibrinogen gamma chain FGL1 0.635 8p22 fibrinogen-like 1 SLC7A2 0.536 8p22 solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 DUSP4 0.521 8p12-p11 dual specificity phosphatase 4 HAL 0.51 12q22-q24.1histidine ammonia-lyase PDE4D 0.499 5q12 phosphodiesterase 4D, cAMP-specific FURIN 0.497 15q26.1 furin (paired basic amino acid cleaving enzyme) CPS1 0.49 2q35 carbamoyl-phosphate synthase 1, mitochondrial TESC 0.478 12q24.22 tescalcin INHA 0.465 2q35 inhibin, alpha S100P 0.461 4p16 S100 calcium binding protein P VPS37A 0.447 8p22 vacuolar protein sorting 37 homolog A (S. cerevisiae) SLC16A14 0.447 2q36.3 solute carrier family 16, member 14 PPARGC1A 0.443 4p15.1 peroxisome proliferator-activated receptor gamma, coactivator 1 alpha SIK1 0.435 21q22.3 salt-inducible kinase 1 IRS2 0.434 13q34 insulin receptor substrate 2 RND1 0.433 12q12 Rho family GTPase 1 HGD 0.433 3q13.33 homogentisate 1,2-dioxygenase PTP4A1 0.432 6q12 protein tyrosine phosphatase type IVA, member 1 C8orf4 0.428 8p11.2 chromosome 8 open reading frame 4 DDC 0.427 7p12.2 dopa decarboxylase (aromatic L-amino acid decarboxylase) TACC2 0.427 10q26 transforming, acidic coiled-coil containing protein 2 MUC13 0.422 3q21.2 mucin 13, cell surface associated C5 0.412 9q33-q34 complement component 5 NR4A2 0.412 2q22-q23 nuclear receptor subfamily 4, group A, member 2 EYS 0.411 6q12 eyes shut homolog (Drosophila) GPX2 0.406 14q24.1 glutathione peroxidase
    [Show full text]
  • Human Induced Pluripotent Stem Cell–Derived Podocytes Mature Into Vascularized Glomeruli Upon Experimental Transplantation
    BASIC RESEARCH www.jasn.org Human Induced Pluripotent Stem Cell–Derived Podocytes Mature into Vascularized Glomeruli upon Experimental Transplantation † Sazia Sharmin,* Atsuhiro Taguchi,* Yusuke Kaku,* Yasuhiro Yoshimura,* Tomoko Ohmori,* ‡ † ‡ Tetsushi Sakuma, Masashi Mukoyama, Takashi Yamamoto, Hidetake Kurihara,§ and | Ryuichi Nishinakamura* *Department of Kidney Development, Institute of Molecular Embryology and Genetics, and †Department of Nephrology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan; ‡Department of Mathematical and Life Sciences, Graduate School of Science, Hiroshima University, Hiroshima, Japan; §Division of Anatomy, Juntendo University School of Medicine, Tokyo, Japan; and |Japan Science and Technology Agency, CREST, Kumamoto, Japan ABSTRACT Glomerular podocytes express proteins, such as nephrin, that constitute the slit diaphragm, thereby contributing to the filtration process in the kidney. Glomerular development has been analyzed mainly in mice, whereas analysis of human kidney development has been minimal because of limited access to embryonic kidneys. We previously reported the induction of three-dimensional primordial glomeruli from human induced pluripotent stem (iPS) cells. Here, using transcription activator–like effector nuclease-mediated homologous recombination, we generated human iPS cell lines that express green fluorescent protein (GFP) in the NPHS1 locus, which encodes nephrin, and we show that GFP expression facilitated accurate visualization of nephrin-positive podocyte formation in
    [Show full text]
  • Discovering Bioactive Peptides and Characterizing the Molecular Pathways That Control Their Activity
    Discovering Bioactive Peptides and Characterizing the Molecular Pathways that Control Their Activity The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters Citation Mitchell, Andrew. 2012. Discovering Bioactive Peptides and Characterizing the Molecular Pathways that Control Their Activity. Doctoral dissertation, Harvard University. Citable link http://nrs.harvard.edu/urn-3:HUL.InstRepos:9406016 Terms of Use This article was downloaded from Harvard University’s DASH repository, and is made available under the terms and conditions applicable to Other Posted Material, as set forth at http:// nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of- use#LAA Copyright © 2012 by Andrew James Mitchell All rights reserved. Professor Alan Saghatelian Andrew James Mitchell Discovering Bioactive Peptides and Characterizing the Molecular Pathways that Control Their Activity Abstract Bioactive peptides constitute a major class of signaling molecules in animals and have been shown to play a role in diverse physiological processes, including hypertension, appetite and sleep. As a result, knowing the identity of these molecules and understanding the mechanisms by which they are regulated has basic and medical significance. In this dissertation, I describe the development and application of novel methods for discovering bioactive peptides and the molecular pathways that control their activity. Recent analyses of mammalian RNAs have revealed the translation of numerous short open reading frames (sORFs). However, it is unknown whether these translation events produce stable polypeptide products that persist in the cell at functionally relevant concentrations. In Chapter 1, I describe a study in which we used a novel mass spectrometry-based strategy to directly detect sORF-encoded polypeptides (SEPs) in human cells.
    [Show full text]
  • Role of PITRM1 in Mitochondrial Dysfunction and Neurodegeneration
    biomedicines Review Role of PITRM1 in Mitochondrial Dysfunction and Neurodegeneration Dario Brunetti 1,2 , Alessia Catania 2, Carlo Viscomi 3, Michela Deleidi 4, Laurence A. Bindoff 5,6, Daniele Ghezzi 2,7,* and Massimo Zeviani 8,9,* 1 Department of Medical Biotechnology and Translational Medicine, University of Milan, 20129 Milan, Italy; [email protected] 2 Unit of Medical Genetics and Neurogenetics, Fondazione IRCCS Istituto Neurologico Carlo Besta, 20126 Milan, Italy; [email protected] 3 Department of Biomedical Sciences, University of Padova, 35131 Padova, Italy; [email protected] 4 German Center for Neurodegenerative Diseases (DZNE), 72076 Tübingen, Germany; [email protected] 5 Neuro-SysMed, Center of Excellence for Clinical Research in Neurological Diseases, Haukeland University Hospital, N-5021 Bergen, Norway; [email protected] 6 Department of Clinical Medicine, University of Bergen, N-5021 Bergen, Norway 7 Department of Pathophysiology and Transplantation, University of Milan, 20122 Milan, Italy 8 Department of Neurosciences, University of Padova, 35128 Padova, Italy 9 Venetian Institute of Molecular Medicine, 35128 Padova, Italy * Correspondence: [email protected] (D.G.); [email protected] (M.Z.) Abstract: Mounting evidence shows a link between mitochondrial dysfunction and neurodegenera- tive disorders, including Alzheimer Disease. Increased oxidative stress, defective mitodynamics, and impaired oxidative phosphorylation leading to decreased ATP production, can determine synaptic dysfunction, apoptosis, and neurodegeneration. Furthermore, mitochondrial proteostasis and the Citation: Brunetti, D.; Catania, A.; protease-mediated quality control system, carrying out degradation of potentially toxic peptides Viscomi, C.; Deleidi, M.; Bindoff, L.A.; and misfolded or damaged proteins inside mitochondria, are emerging as potential pathogenetic Ghezzi, D.; Zeviani, M.
    [Show full text]
  • Handbook of Proteolytic Enzymes Second Edition Volume 1 Aspartic and Metallo Peptidases
    Handbook of Proteolytic Enzymes Second Edition Volume 1 Aspartic and Metallo Peptidases Alan J. Barrett Neil D. Rawlings J. Fred Woessner Editor biographies xxi Contributors xxiii Preface xxxi Introduction ' Abbreviations xxxvii ASPARTIC PEPTIDASES Introduction 1 Aspartic peptidases and their clans 3 2 Catalytic pathway of aspartic peptidases 12 Clan AA Family Al 3 Pepsin A 19 4 Pepsin B 28 5 Chymosin 29 6 Cathepsin E 33 7 Gastricsin 38 8 Cathepsin D 43 9 Napsin A 52 10 Renin 54 11 Mouse submandibular renin 62 12 Memapsin 1 64 13 Memapsin 2 66 14 Plasmepsins 70 15 Plasmepsin II 73 16 Tick heme-binding aspartic proteinase 76 17 Phytepsin 77 18 Nepenthesin 85 19 Saccharopepsin 87 20 Neurosporapepsin 90 21 Acrocylindropepsin 9 1 22 Aspergillopepsin I 92 23 Penicillopepsin 99 24 Endothiapepsin 104 25 Rhizopuspepsin 108 26 Mucorpepsin 11 1 27 Polyporopepsin 113 28 Candidapepsin 115 29 Candiparapsin 120 30 Canditropsin 123 31 Syncephapepsin 125 32 Barrierpepsin 126 33 Yapsin 1 128 34 Yapsin 2 132 35 Yapsin A 133 36 Pregnancy-associated glycoproteins 135 37 Pepsin F 137 38 Rhodotorulapepsin 139 39 Cladosporopepsin 140 40 Pycnoporopepsin 141 Family A2 and others 41 Human immunodeficiency virus 1 retropepsin 144 42 Human immunodeficiency virus 2 retropepsin 154 43 Simian immunodeficiency virus retropepsin 158 44 Equine infectious anemia virus retropepsin 160 45 Rous sarcoma virus retropepsin and avian myeloblastosis virus retropepsin 163 46 Human T-cell leukemia virus type I (HTLV-I) retropepsin 166 47 Bovine leukemia virus retropepsin 169 48
    [Show full text]
  • Cloning, Expression and Characterization of Insulin-Degrading Enzyme from Tomato (Solanum Lycopersicum)
    Article in press - uncorrected proof Biol. Chem., Vol. 389, pp. 91–98, January 2008 • Copyright ᮊ by Walter de Gruyter • Berlin • New York. DOI 10.1515/BC.2008.006 Cloning, expression and characterization of insulin-degrading enzyme from tomato (Solanum lycopersicum) Yoann Huet1,a, Jochen Strassner2 and Andreas named inverzincins (Ding et al., 1992). It was demonstrat- Schaller1,* ed by site-directed mutagenesis that the two histidine residues are involved in the coordination of the zinc ion, 1 Institute of Plant Physiology and Biotechnology, while the glutamate is required for catalysis (Perlman et University of Hohenheim, D-70593 Stuttgart, Germany al., 1993; Becker and Roth, 1995). 2 Altana Pharma AG, D-78467 Konstanz, Germany Inverzincins generally accept a wide variety of peptide * Corresponding author substrates and appear to lack selectivity for specific e-mail: [email protected] sequence motives in the primary structure of their sub- strates. Indeed, IDE was shown to cleave many different peptides, including insulin and glucagon (Kirschner and Abstract Goldberg, 1983), natriuretic peptides (Muller et al., 1992), transforming growth factor a (Garcia et al., 1989; Gehm A cDNA encoding insulin-degrading enzyme (IDE) was and Rosner, 1991), b-endorphin and dynorphins (Safavi cloned from tomato (Solanum lycopersicum) and et al., 1996), growth hormone releasing factor (Garcia expressed in Escherichia coli in N-terminal fusion with et al., 1989), amylin (Bennett et al., 2000) and amyloid glutathione S-transferase. GST-SlIDE was characterized b peptide (Qiu et al., 1998; Vekrellis et al., 2000) at unre- as a neutral thiol-dependent metallopeptidase with insu- lated sites. However, despite the degeneracy of cleavage linase activity: the recombinant enzyme cleaved the oxi- sites, these peptide substrates are recognized by IDE dized insulin B chain at eight peptide bonds, six of which and cleaved with high affinity, while other biologically are also targets of human IDE.
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2004/0081648A1 Afeyan Et Al
    US 2004.008 1648A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2004/0081648A1 Afeyan et al. (43) Pub. Date: Apr. 29, 2004 (54) ADZYMES AND USES THEREOF Publication Classification (76) Inventors: Noubar B. Afeyan, Lexington, MA (51) Int. Cl." ............................. A61K 38/48; C12N 9/64 (US); Frank D. Lee, Chestnut Hill, MA (52) U.S. Cl. ......................................... 424/94.63; 435/226 (US); Gordon G. Wong, Brookline, MA (US); Ruchira Das Gupta, Auburndale, MA (US); Brian Baynes, (57) ABSTRACT Somerville, MA (US) Disclosed is a family of novel protein constructs, useful as Correspondence Address: drugs and for other purposes, termed “adzymes, comprising ROPES & GRAY LLP an address moiety and a catalytic domain. In Some types of disclosed adzymes, the address binds with a binding site on ONE INTERNATIONAL PLACE or in functional proximity to a targeted biomolecule, e.g., an BOSTON, MA 02110-2624 (US) extracellular targeted biomolecule, and is disposed adjacent (21) Appl. No.: 10/650,592 the catalytic domain So that its affinity Serves to confer a new Specificity to the catalytic domain by increasing the effective (22) Filed: Aug. 27, 2003 local concentration of the target in the vicinity of the catalytic domain. The present invention also provides phar Related U.S. Application Data maceutical compositions comprising these adzymes, meth ods of making adzymes, DNA's encoding adzymes or parts (60) Provisional application No. 60/406,517, filed on Aug. thereof, and methods of using adzymes, Such as for treating 27, 2002. Provisional application No. 60/423,754, human Subjects Suffering from a disease, Such as a disease filed on Nov.
    [Show full text]
  • A Genomic Analysis of Rat Proteases and Protease Inhibitors
    A genomic analysis of rat proteases and protease inhibitors Xose S. Puente and Carlos López-Otín Departamento de Bioquímica y Biología Molecular, Facultad de Medicina, Instituto Universitario de Oncología, Universidad de Oviedo, 33006-Oviedo, Spain Send correspondence to: Carlos López-Otín Departamento de Bioquímica y Biología Molecular Facultad de Medicina, Universidad de Oviedo 33006 Oviedo-SPAIN Tel. 34-985-104201; Fax: 34-985-103564 E-mail: [email protected] Proteases perform fundamental roles in multiple biological processes and are associated with a growing number of pathological conditions that involve abnormal or deficient functions of these enzymes. The availability of the rat genome sequence has opened the possibility to perform a global analysis of the complete protease repertoire or degradome of this model organism. The rat degradome consists of at least 626 proteases and homologs, which are distributed into five catalytic classes: 24 aspartic, 160 cysteine, 192 metallo, 221 serine, and 29 threonine proteases. Overall, this distribution is similar to that of the mouse degradome, but significatively more complex than that corresponding to the human degradome composed of 561 proteases and homologs. This increased complexity of the rat protease complement mainly derives from the expansion of several gene families including placental cathepsins, testases, kallikreins and hematopoietic serine proteases, involved in reproductive or immunological functions. These protease families have also evolved differently in the rat and mouse genomes and may contribute to explain some functional differences between these two closely related species. Likewise, genomic analysis of rat protease inhibitors has shown some differences with the mouse protease inhibitor complement and the marked expansion of families of cysteine and serine protease inhibitors in rat and mouse with respect to human.
    [Show full text]
  • Peptide Sequence
    Peptide Sequence Annotation AADHDG CAS-L1 AAEAISDA M10.005-stromelysin 1 (MMP-3) AAEHDG CAS-L2 AAEYGAEA A01.009-cathepsin D AAGAMFLE M10.007-stromelysin 3 (MMP-11) AAQNASMW A06.001-nodavirus endopeptidase AASGFASP M04.003-vibriolysin ADAHDG CAS-L3 ADAPKGGG M02.006-angiotensin-converting enzyme 2 ADATDG CAS-L5 ADAVMDNP A01.009-cathepsin D ADDPDG CAS-21 ADEPDG CAS-L11 ADETDG CAS-22 ADEVDG CAS-23 ADGKKPSS S01.233-plasmin AEALERMF A01.009-cathepsin D AEEQGVTD C03.007-rhinovirus picornain 3C AETFYVDG A02.001-HIV-1 retropepsin AETWYIDG A02.007-feline immunodeficiency virus retropepsin AFAHDG CAS-L24 AFATDG CAS-25 AFDHDG CAS-L26 AFDTDG CAS-27 AFEHDG CAS-28 AFETDG CAS-29 AFGHDG CAS-30 AFGTDG CAS-31 AFQHDG CAS-32 AFQTDG CAS-33 AFSHDG CAS-L34 AFSTDG CAS-35 AFTHDG CAS-L36 AGERGFFY Insulin B-chain AGLQRGGG M14.004-carboxypeptidase N AGSHLVEA Insulin B-chain AIDIDG CAS-L37 AIDPDG CAS-38 AIDTDG CAS-39 AIDVDG CAS-L40 AIEHDG CAS-L41 AIEIDG CAS-L42 AIENDG CAS-43 AIEPDG CAS-44 AIEQDG CAS-45 AIESDG CAS-46 AIETDG CAS-47 AIEVDG CAS-48 AIFQGPID C03.007-rhinovirus picornain 3C AIGHDG CAS-49 AIGNDG CAS-L50 AIGPDG CAS-L51 AIGQDG CAS-52 AIGSDG CAS-53 AIGTDG CAS-54 AIPMSIPP M10.051-serralysin AISHDG CAS-L55 AISNDG CAS-L56 AISPDG CAS-57 AISQDG CAS-58 AISSDG CAS-59 AISTDG CAS-L60 AKQRAKRD S08.071-furin AKRQGLPV C03.007-rhinovirus picornain 3C AKRRAKRD S08.071-furin AKRRTKRD S08.071-furin ALAALAKK M11.001-gametolysin ALDIDG CAS-L61 ALDPDG CAS-62 ALDTDG CAS-63 ALDVDG CAS-L64 ALEIDG CAS-L65 ALEPDG CAS-L66 ALETDG CAS-67 ALEVDG CAS-68 ALFQGPLQ C03.001-poliovirus-type picornain
    [Show full text]
  • EBNA2) Target Genes
    Identification and Functional Analysis of Epstein-Barr Virus Nuclear Antigen 2 (EBNA2) Target Genes A Thesis Submitted for the Degree of Doctor of Natural Sciences Faculty of Biology, Ludwig-Maximilians-Universität München Maja Š Munich, November 2003 Completed at the GSF Research Centre for Environment and Health GmbH Institute for Clinical Molecular Biology and Tumour Genetics, Munich First Examiner: PD Dr. Bettina Kempkes Second Examiner: Prof. Dr. Heinrich Leonhardt Additional Examiners: Prof. Dr. Walter Schartau Prof. Dr. Hans Weiher Date of the oral examination: June 25th, 2004 LIST OF ABBREVIATIONS A adenosine AIDS acquired immune deficiency syndrome BL ’lymphoma bp base pair BrdU 5-bromo-’-deoxy-uridine BSA bovine serum albumine C cytosine CD cluster of differentiation Cdk4 cycline-dependent kinase 4 cDNA complementary DNA ChIP chromatin immunoprecipitation CHX cycloheximide Ci Curie CMV cytomegalovirus CR2 complement receptor type 2 cRNA complementary RNA CTP cytosine triphosphate dCTP deoxycitosine triphosphate DEPC diethyl pyrocarbonate DIG digoxigenin-dUTP DNA ’-deoxyribonucleic acid dNTP ’-deoxyribonucleoside-’ DPM degradations per minute dsRNA double-stranded RNA DTT dithiotreitol dUTP deoxyuridine triphosphate E.coli Escherichia coli e.g. for example (lat. exempli gratia) EBER EBV-encoded RNA EBNA Epstein-Barr nuclear antigen EBV Epstein-Barr virus EDTA ethylene diamine tetra-acetic acid ELISA enzyme linked immunosorbent assay EMSA electromobility shift assay ER/EBNA2 oestrogen receptor/Epstein-Barr nuclear antigen 2 EST expressed sequence tag FCS foetal calf serum Fig. figure G guanidine GAPDH glyceraldehyde 3-phosphate dehydrogenase GC germinal centre GM-CSF granulocyte-macrophage colony-stimulating factor h hour HAT histone acetyltransferase HD ’disease HDAC histone deacetylase complex HHV4 human herpesvirus 4 HIV human immunodeficiency virus Hsp90 heat shock protein 90 i.e.
    [Show full text]
  • Mitochondrial Protein Quality Control in Cancer
    International Journal of Molecular Sciences Review Failure to Guard: Mitochondrial Protein Quality Control in Cancer Joseph E. Friedlander 1,†, Ning Shen 1,2,†, Aozhuo Zeng 1, Sovannarith Korm 1 and Hui Feng 1,2,* 1 Department of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, MA 02118, USA; [email protected] (J.E.F.); [email protected] (N.S.); [email protected] (A.Z.); [email protected] (S.K.) 2 Department of Medicine, Section of Hematology and Medical Oncology, Boston University School of Medicine, Boston, MA 02118, USA * Correspondence: [email protected]; Tel.: +1-617-358-4688; Fax: +1-617-358-1599 † Equal contribution. Abstract: Mitochondria are energetic and dynamic organelles with a crucial role in bioenergetics, metabolism, and signaling. Mitochondrial proteins, encoded by both nuclear and mitochondrial DNA, must be properly regulated to ensure proteostasis. Mitochondrial protein quality control (MPQC) serves as a critical surveillance system, employing different pathways and regulators as cellular guardians to ensure mitochondrial protein quality and quantity. In this review, we describe key pathways and players in MPQC, such as mitochondrial protein translocation-associated degradation, mitochondrial stress responses, chaperones, and proteases, and how they work together to safeguard mitochondrial health and integrity. Deregulated MPQC leads to proteotoxicity and dysfunctional mitochondria, which contributes to numerous human diseases, including cancer. We discuss how alterations in MPQC components are linked to tumorigenesis, whether they act as drivers, suppressors, or both. Finally, we summarize recent advances that seek to target these Citation: Friedlander, J.E.; Shen, N.; alterations for the development of anti-cancer drugs. Zeng, A.; Korm, S.; Feng, H.
    [Show full text]